Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SSL Expert Dr. Bernhard Stapp Joins Board of Aledia

Published: Monday, May 27, 2013
Last Updated: Monday, May 27, 2013
Bookmark and Share
Former OSRAM general manager and CTO has played key role in industry’s evolution, will aid Aledia’s move towards industrialization.

Aledia has announced that solid-state lighting (SSL) industry veteran Dr. Bernhard Stapp has joined its board of directors.

Stapp brings more than a dozen years of executive experience in LED lighting technologies to Aledia, most recently in senior management positions at OSRAM, a global leader in SSL manufacturing and marketing.

As general manager and senior vice president of OSRAM AG’s SSL unit, Stapp was responsible for the company’s professional LED and OLED business.

Earlier, as SSL vice president and general manager at OSRAM Opto Semiconductors, he launched and managed the general-lighting LED business and oversaw launch of the world’s first OLED lighting products.

Prior to that, Stapp was vice president and CTO of the semiconductor company, where he oversaw global LED, laser and OLED R&D.

Earlier in his career, he held a variety of management positions in Siemens AG’s Corporate Technology division.

“Aledia’s mission is to bring fundamental change to the world’s lighting markets by making LED technology substantially more affordable and more versatile, with better performance and fewer limitations,” said Giorgio Anania, Aledia’s co-founder, president and CEO.

Anania continued, “Bernhard has been a key player at the heart of the global LED industry since its inception, and also has an outstanding technical background. His unique perspective on this industry’s future will be invaluable as Aledia moves into the next stage of its evolution.”

WireLED®, Aledia’s unique 3D microwire GaN-on-silicon technology, was developed at the CEA-Leti nanotech research institute in Grenoble.

It addresses the basic technical and economic challenges facing LED lighting by allowing production of LEDs on inexpensive industry-standard 200mm silicon wafers using standard semiconductor processes and tools.

“Aledia’s technology is, quite simply, a breakthrough for the entire LED sector,” said Stapp. “It can meet the industry’s critical requirement for cost-reduction, while using far simpler production processes and much less material than conventional approaches. I am very excited about the opportunity to join this team.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Madison Researchers Begin Work on Zika Virus
Work will start with basic questions about Zika virus infection.
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Drug that Activates Innate Immune System Identified
Researchers from the institute have identified a drug, which is straightforward to synthesize and to couple to antigens that induce an immune response and may prove useful in the generation of vaccines.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!